United Therapeutics Corp. (UTHR)
513.04
-0.08
(-0.02%)
USD |
NASDAQ |
Aug 24, 16:00
513.04
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Enterprise Value : 19.24B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 19.24B |
| August 20, 2026 | 19.57B |
| August 19, 2026 | 19.92B |
| August 18, 2026 | 19.46B |
| August 17, 2026 | 19.04B |
| August 14, 2026 | 18.66B |
| August 13, 2026 | 18.73B |
| August 12, 2026 | 19.18B |
| August 11, 2026 | 19.34B |
| August 10, 2026 | 19.94B |
| August 07, 2026 | 20.33B |
| August 06, 2026 | 20.08B |
| August 05, 2026 | 19.49B |
| August 04, 2026 | 19.47B |
| August 03, 2026 | 19.37B |
| July 31, 2026 | 19.43B |
| July 30, 2026 | 19.78B |
| July 29, 2026 | 19.73B |
| July 28, 2026 | 19.68B |
| July 27, 2026 | 19.87B |
| July 24, 2026 | 19.89B |
| July 23, 2026 | 19.94B |
| July 22, 2026 | 19.83B |
| July 21, 2026 | 20.21B |
| July 20, 2026 | 19.93B |
| Date | Value |
|---|---|
| July 17, 2026 | 20.20B |
| July 16, 2026 | 19.92B |
| July 15, 2026 | 20.03B |
| July 14, 2026 | 19.81B |
| July 13, 2026 | 20.19B |
| July 10, 2026 | 20.68B |
| July 09, 2026 | 20.92B |
| July 08, 2026 | 21.00B |
| July 07, 2026 | 21.39B |
| July 06, 2026 | 20.69B |
| July 02, 2026 | 21.06B |
| July 01, 2026 | 20.69B |
| June 30, 2026 | 20.46B |
| June 29, 2026 | 20.82B |
| June 26, 2026 | 20.72B |
| June 25, 2026 | 20.75B |
| June 24, 2026 | 21.03B |
| June 23, 2026 | 20.79B |
| June 22, 2026 | 20.54B |
| June 18, 2026 | 20.47B |
| June 17, 2026 | 21.09B |
| June 16, 2026 | 20.96B |
| June 15, 2026 | 21.01B |
| June 12, 2026 | 20.86B |
| June 11, 2026 | 20.84B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Liquidia Corp. | 6.013B |
| Insmed, Inc. | 27.04B |
| MannKind Corp. | 1.611B |
| Vertex Pharmaceuticals, Inc. | 132.96B |
| BioMarin Pharmaceutical, Inc. | 16.25B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 333.00M |
| Revenue (Quarterly) | 783.30M |
| Total Expenses (Quarterly) | 450.30M |
| EPS Diluted (Quarterly) | 7.271 |
| Gross Profit Margin (Quarterly) | 87.30% |
| Profit Margin (Quarterly) | 42.51% |
| Earnings Yield | 5.45% |
| Operating Earnings Yield | 5.83% |
| Normalized Earnings Yield | 5.085 |